Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Inevitable dilution. Uncertain outcome of clinical tests.My experience of warrants is that they become worthless. As an LTH i cannot but hold on.I knew the risks and only myself to blame. Ultimately i know my loss which though substantial i can bear. Just another AIM bio company casualty.Nothing new it keeps on happening. I do not believe in miracles.
At these levels there is no other alternative but to hold IMO. It is clearly evident to me that the market knows something we don't know. These are not normal price fluctuations but a true and proper Armageddon.Dilution is now inevitable to keep the company afloat. Having blind faith in the science is not enough.Got to be backed up by hard cash or else Sareum will imply end up as another AIM casualty. Does not look good at all. possibility that company taken over for a pittance .
Good luck Amers. You have guts.
Regretfully potnak, the possibility of missing deadlines is very real with Sareum. The market is sensing this and hence the extreme price weakness. I am still an LTH but i must admit i am losing faith and as you aptly put it i do have my "breaking point". With the SP plummeting i feel as an LTH that i have been left holding the baby. My consolation is that i put in capital i can afford to lose but really i was naive in not taking profits in an AIM share where really there is no protection for investors.
HarChris make an effort not to live in denial and face facts. The price was whipped up to astronomical figures simply as a means for the previous Chairman to cash in and run away. He handed the baby to his successors knowing well enough that there was no strategic growth plan no distribution network. The feud with the DHSC was the proverbial last straw that broke the camels back. Not confident that the case will be won and the weakness in the SP seems to indicate the distinct possibility of this happening following which the possibility of a rights issue is real which would further dilute shareholder value. Not a pretty picture at all. The acquisition of Yourgene and its financial impact on Novacyt in my view remains untested.Can only see the SP drift further south.
Good luck Amers. You certainly need it.
Good luck Amers.
I consider myself as a LTH and generally ignore the wild fluctuations in price which is so common on AIM shares. But for the first time doubts are creeping in my mind as to whether the weakness in the price is " just AIM" or else the expectation of disappointing news. Admittedly the share remain in the high risk category which i accept. But i now feel that the " no news " is " good news" argument is now not a valid argument. Might be and hope i am wrong on this.
Very simple HarChris its "abandon ship" No reason why one should invest in a rudderless company with no vision or business plan. Market sensing that the cash burn will accelerate. Will stand by my 10p SP price before DHSC ruling10 .
P100 ---it is amply evident that the only aim the BOD have is to dip into the honey pot .No strategy whatsoever and no vision for the company. By the time the DHSC ruling falls due the SP will be in the 10p region and the bank balance significantly down. Cannot see or identify any catalyst for growth at this stage and the market is realising this.A slow and painful demise for the company.
Spot on Potnak.
P100. So many so called investors here are living in denial. Said many times this company is a rudderless ship with a drunken captain. From time to time "good" news surfaces and lures in more unwary investors. With this inept BOD there is no future for the company and at best will be swallowed up by a bigger company for peanuts .
Certainly not 'sitting' here waiting for 10pif that is what you think i'm doing. It's not how much cash you have in the bank it's how you use it. Till now the BOD have shown that they are not competent enough to invest that cash wisely. Former Chairman manipulated news in such a way to get his " performance"bonus and leave investors carrying the baby with a dirty nappy. That is inexcusable.
You are right Moniman, this is now a trading share if you are nimble enough. SP rises lure inexperienced investors with the more astute ones gladly giving them the shares.
Well HarChris, i see you are ready to pop the Champagne. I have absolutely no interest or wish to see the SP at 10p. IMO the BOD is weak and drags its feet and the ygen deal is not yet in the bag as there is still the possibility of another bidder. The DHSC issue still pending and many predict or speculate a favourable outcome. Hopefully it would be so but no guarantees.
One more time suckers drawn in to buying. Incredible. Once bitten...twice bitten ....three times bitten and you never learn.
Typical trend of ta share which is awaiting clinical results. Investors who cannot stomach this kind of volatility should not be in Sareum. Can go either way.
PI100 ....."improvements are surely due...." Nothing is sure with this awfully managed company. Market has no confidence in the company and investors will stay away and will not buy the bla bla bla. Steadily down to the 10p level with small blips along the slippery path.
Always said that 50p will be the first target. But it does not stop here. The company has the potential.............to be worthless. No catalyst to turn it around. Weak management, lack of sales, dwindling revenues .A possible negative DHSC decision which will eliminate the cash balance, will simply tank the SP and back to the 10 p territory at best.
And SHAMBLES it is P100. Next medium term target 10p and the DHSC ruling ...............